XML 35 R16.htm IDEA: XBRL DOCUMENT v3.26.1
Stock Options
 12 Months Ended
Dec. 31, 2025
Stock Options [Abstract]  
STOCK OPTIONS

NOTE 8 – STOCK OPTIONS

 

On January 3, 2024, the Company granted stock options to purchase 20,000 shares of common stock pursuant to the terms of the Company’s employment agreement with Mr. Yakov. 50% of the options vested immediately, 25% of the options vest on the one-year anniversary of the grant, and 25% of the options vest on the two-year anniversary of the grant. The options have an exercise price of $0.10 per share. The aggregate fair value of the options totaled $541,999 based on the Black Scholes Merton pricing model using the following estimates: exercise price of $0.01 (pre-split pricing), 1.63% risk free rate, 295% volatility and expected life of the options of 10 years. The fair value of the options will be recognized over the vesting period with credits to additional paid in capital.

 

On January 24, 2024, Mr. Yakov exercised options to purchase a total of 118,792 shares of common stock for $4,079 (see Note 11 and Note 13). 

 

On January 24, 2024, Mr. Smith exercised options to purchase a total of 38,107 shares of common stock for $2,761 (see Note 11 and Note 13).

 

A summary of the status of the Company’s outstanding stock options and changes is presented below:

 

Stock Options  Options   Weighted
Average
Exercise
Price		   Aggregate
Intrinsic
Value		 
Options outstanding December 31, 2023   156,899   $0.04   $1,656,270 
Granted   20,000   $0.10      
Exercised   (156,899)  $0.04      
Expired   
—
   $
—
      
Options outstanding December 31, 2024   20,000   $0.10   $39,400 
Granted   
—
    
 
      
Exercised   
—
    
 
      
Expired   
—
    
 
      
Options outstanding December 31, 2025   20,000   $0.10   $10,388 
Shares exercisable at December 31, 2025   20,000   $0.10   $10,388 

 

During the years ended December 31, 2025 and 2024, the Company recognized $135,500 and $406,500, respectively, in stock-based compensation related to the above-mentioned options. As of December 31, 2025 there was $0 of unrecognized expense for the above-mentioned options. The weighted average contractual term of the options outstanding and of the option exercisable were 8.01 years.